![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, August 17, 2013 5:13:08 PM
2. I had time to read the Jason article. The RP study was reported in the Spring of 2012. Interesting. AND no followup studies have yet been done.
3. Jason notes that Big Pharma will be needed to study MANF for PD. We knew that, but it bears repeating.
4. As some doubted, the Lympro BD study is ongoing with data back in the next few months. If the study is positive, AMBS will most certainly see money from BD or some other company.
5. The key to this is that Pharma could write off RP research immediately due to its orphan status. That would not happen with PD since it is more common than 200000.
6. The key to this RP announcement to me is that the study happened in 2011 and 2012, and was reported in May of 2012. The AMBS release notes that the study was reported in 2012. It does mention the month. No wonder why the stock did not move. Amazing. One other thing, the study was an abstract. IOW it was not accepted for publication by a major opthamologic publication. While not getting accepted is the norm, it speaks against the process in general.
7. The pps is probably now in an uptrend. For a brief period there are higher lows and higher highs. WHEN and if the pps STAYS above teh 50 day MA, then we will have an uptrend.
8. However, this RP release is yet another PR move, accompanied by multiple sources of pumping. In the past this indicated that a HUGE dilution was coming. Oh well. With all of this, and the LATE SEC filing, I would EXPECT a HUGE dilution ahead.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM